|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Expenses | |||||
| Research and development expenses | |||||
| General and administrative expenses | |||||
| Operating Loss | |||||
| Other Income (Expense) | |||||
| Other income | |||||
| Unrealized gain on digital assets at fair value | |||||
| Interest and dividend income, net | |||||
| Net Operating Loss Before Income Tax Benefit | |||||
| Net Loss | |||||
| Net Loss Per Common Share - Basic | |||||
| Net Loss Per Common Share - Diluted | |||||
| Weighted Average Common Shares Used to Compute Net Loss Per Common Shares - Basic | |||||
| Weighted Average Common Shares Used to Compute Net Loss Per Common Shares - Diluted | |||||
Loading...